Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Varga

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Investigational New Drugs|December 15, 2018
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancerAlexandra Leary, Christophe Le Tourneau, Andrea Varga, et al.
Gynecologic Oncology|December 8, 2018
Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028Andrea Varga, Sarina Piha-Paul, Patrick A Ott, et al.
The FEBS Journal|March 5, 2019
RAF dimers control vascular permeability and cytoskeletal rearrangements at endothelial cell-cell junctionsCoralie Dorard, Botond Cseh, Karin Ehrenreiter, et al.
Drug Safety|June 29, 2020
Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on HepatotoxicityJames H Lewis, Paul H Cottu, Martin Lehr, et al.
Cancer Chemotherapy and Pharmacology|April 8, 2014
Pharmacokinetics of pazopanib administered in combination with bevacizumabDiane-Charlotte Imbs, Sylvie Négrier, Philippe Cassier, et al.
Scientific Reports|August 13, 2017
Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influenceLaurent Dercle, Samy Ammari, Mathilde Bateson, et al.
Orvosi Hetilap|November 8, 2016
[The first 200 transcatheter aortic valve implantations in the Gottsegen Gyorgy Institute of Cardiology, Hungary]Géza Fontos, Gábor Dékány, Nikolett Hegedüs, et al.
Journal of Geriatric Oncology|September 12, 2017
Are phase I trials safe for older patients?Capucine Baldini, Olivia Le Saux, Carole Helissey, et al.
Journal of Clinical Medicine|August 26, 2023
The Effect of Circle of Willis Morphology on Retinal Blood Flow in Patients with Carotid Stenosis Measured by Optical Coherence Tomography AngiographyZsuzsanna Mihály, Lilla István, Cecilia Czakó, et al.
British Journal of Cancer|October 30, 2015
Phase I study of afatinib combined with nintedanib in patients with advanced solid tumoursRastislav Bahleda, Antoine Hollebecque, Andrea Varga, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Investigational New Drugs|December 15, 2018
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancerAlexandra Leary, Christophe Le Tourneau, Andrea Varga, et al.
Gynecologic Oncology|December 8, 2018
Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028Andrea Varga, Sarina Piha-Paul, Patrick A Ott, et al.
The FEBS Journal|March 5, 2019
RAF dimers control vascular permeability and cytoskeletal rearrangements at endothelial cell-cell junctionsCoralie Dorard, Botond Cseh, Karin Ehrenreiter, et al.
Drug Safety|June 29, 2020
Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on HepatotoxicityJames H Lewis, Paul H Cottu, Martin Lehr, et al.
Cancer Chemotherapy and Pharmacology|April 8, 2014
Pharmacokinetics of pazopanib administered in combination with bevacizumabDiane-Charlotte Imbs, Sylvie Négrier, Philippe Cassier, et al.
Scientific Reports|August 13, 2017
Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influenceLaurent Dercle, Samy Ammari, Mathilde Bateson, et al.
Orvosi Hetilap|November 8, 2016
[The first 200 transcatheter aortic valve implantations in the Gottsegen Gyorgy Institute of Cardiology, Hungary]Géza Fontos, Gábor Dékány, Nikolett Hegedüs, et al.
Journal of Geriatric Oncology|September 12, 2017
Are phase I trials safe for older patients?Capucine Baldini, Olivia Le Saux, Carole Helissey, et al.
Journal of Clinical Medicine|August 26, 2023
The Effect of Circle of Willis Morphology on Retinal Blood Flow in Patients with Carotid Stenosis Measured by Optical Coherence Tomography AngiographyZsuzsanna Mihály, Lilla István, Cecilia Czakó, et al.
British Journal of Cancer|October 30, 2015
Phase I study of afatinib combined with nintedanib in patients with advanced solid tumoursRastislav Bahleda, Antoine Hollebecque, Andrea Varga, et al.
Pageof 11